News
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
The field of Cancer Immunity & Immunotherapy is entering an exciting new phase. While Volume I (see here) of this Research Topic highlighted broad ...
Artificial intelligence (AI) technologies and machine learning (ML) algorithms are witnessing tremendous growth in immunology ...
Researchers are praising the results of two studies that used immunotherapy to fight one of the most difficult-to-treat types of brain cancer, glioblastoma. The studies used CAR-T therapy, which uses ...
Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of those who did not respond to the latest cancer treatments, known as immune ...
Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.
Population model successfully developed to characterize BI-1910 pharmacokinetics and pharmacodynamics across a broad range of ...
Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...
The strategic collaboration includes an exchange of Agenus' state-of-the-art biologics CMC facilities in Emeryville, CA and Berkeley, CA for upfront consideration of $75M; Agenus to receive up to an ...
HOUSTON, TX, USA and CHICAGO, IL, USA I May 29, 2025 I RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results